BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 191204)

  • 1. Studies on viomycin IX. Amino acid derivatives on viomycin.
    Kitagawa T; Miura T; Takaishi C; Taniyama H
    Chem Pharm Bull (Tokyo); 1976 Jun; 24(6):1324-30. PubMed ID: 191204
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on viomycin. VII. Oxidative modifications of viomycin.
    Kitagawa T; Miura T; Sawada Y; Fujiwara K; Ito R
    Chem Pharm Bull (Tokyo); 1974 Aug; 22(8):1827-34. PubMed ID: 4371987
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on viomycin. VIII. Selective modifications of the terminal amino groups of viomycin.
    Kitagawa T; Miura T; Takaishi M; Taniyama H
    Chem Pharm Bull (Tokyo); 1975 Sep; 23(9):2123-7. PubMed ID: 171092
    [No Abstract]   [Full Text] [Related]  

  • 4. [Derivatives of viomycin. V. Di(oxytetracyclinemethyl)viomycin and tri(oxytetracyclinemethyl)viomycin, preparation and properties].
    Sobiczewski W; Cieślak J; Chojnowski W; Waszkiewicz A
    Acta Pol Pharm; 1969; 26(3):237-40. PubMed ID: 4308291
    [No Abstract]   [Full Text] [Related]  

  • 5. [Derivatives of viomycin. 3. Viomycin-methyltetracyclines, their preparation and properties].
    Sobiczewski W; Chojnowski W; Waszkiewicz A
    Acta Pol Pharm; 1968; 25(6):563-7. PubMed ID: 4307876
    [No Abstract]   [Full Text] [Related]  

  • 6. [Viomycin derivatives. IV. Preparation and properties of some penicillinates].
    Sobiczewski W; Cieślak J; Chojnowski W; Waszkiewicz A; Cendrowska H
    Acta Pol Pharm; 1969; 26(1):29-32. PubMed ID: 4305691
    [No Abstract]   [Full Text] [Related]  

  • 7. [Derivatives of viomycin. I. Preparation and properties of viomycin nicotinate and isonicotinate].
    Sobiczewski W; Cieślak J; Waszkiewicz A; Chojnowski W
    Acta Pol Pharm; 1968; 25(4):403-5. PubMed ID: 4299475
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on viomycin. XIV. Roles of basic and cyclic moieties in the antimicrobial activity of viomycin.
    Kitagawa T; Miura T; Kurose H
    Chem Pharm Bull (Tokyo); 1979 Nov; 27(11):2551-6. PubMed ID: 230912
    [No Abstract]   [Full Text] [Related]  

  • 9. 13C-nuclear magnetic magnetic resonance studies on viomycin and its related compounds.
    Kitagawa T; Miura T; Mori K; Taniyama H; Kawano K; Kyogoku Y
    Chem Pharm Bull (Tokyo); 1977 Feb; 25(2):280-4. PubMed ID: 192477
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationships between antimicrobial activities and chemical structures of reduced products of viomycin.
    Kitagawa T; Miura T; Tanaka S; Taniyama H
    J Antibiot (Tokyo); 1973 Sep; 26(9):528-31. PubMed ID: 4365319
    [No Abstract]   [Full Text] [Related]  

  • 11. The structure of the guanido amino acid moiety of viomycin.
    Takita T; Maeda K
    J Antibiot (Tokyo); 1968 Aug; 21(8):512-6. PubMed ID: 4303539
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies of some viomycinmethyltetracyclines].
    Sobiczewski W; Cendrowska H; Chojnowski W
    Acta Pol Pharm; 1969; 26(6):505-10. PubMed ID: 4314647
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationships between antimicrobial activities and chemically reactive functions in viomycin.
    Kitagawa T; Miura T; Tanaka S; Taniyama H
    J Antibiot (Tokyo); 1972 Jul; 25(7):429-31. PubMed ID: 4350197
    [No Abstract]   [Full Text] [Related]  

  • 14. The chromophore and partial structure of viomycin.
    Bycroft BW; Cameron D; Croft LR; Hassanali-Walji A; Johnson AW; Webb T
    Tetrahedron Lett; 1968 Dec; (56):5901-4. PubMed ID: 4301558
    [No Abstract]   [Full Text] [Related]  

  • 15. [Derivatives of viomycin. II. Preparation and properties of some viomycin penicillinates].
    Sobiczewski W; Cieślak J; Chojnowski W; Waszkiewicz A; Cendrowska H
    Acta Pol Pharm; 1968; 25(4):407-10. PubMed ID: 4299476
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro microbiological characterization of novel cyclic homopentapeptides, CP-101,680 and CP-163,234, for animal health use.
    Norcia LJ; Silvia AM; Dirlam JP; Schnur RC; Bergeron JM; Retsema JA; Hayashi SF
    J Antibiot (Tokyo); 1999 Nov; 52(11):1007-16. PubMed ID: 10656573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical studies on tuberactinomycin. 3. The chemical structure of viomycin (tuberactinomycin B).
    Noda T; Take T; Nagata A; Wakamiya T; Shiba T
    J Antibiot (Tokyo); 1972 Jul; 25(7):427-8. PubMed ID: 4350196
    [No Abstract]   [Full Text] [Related]  

  • 18. Roles of cyclic structure and dehydro-form amino acid residue in a peptide antibiotic.
    Kitagawa T; Miura T; Taniyama H
    J Biochem; 1977 Jun; 81(6):1759-67. PubMed ID: 197067
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis of some isonicotinoyl- and nicotinoyl-sulphonylamino acid derivatives and their antimicrobial activity.
    el-Naggar AM; Sammour AA; Kora FA; el-Nemma EM
    Farmaco Sci; 1985 Oct; 40(10):786-94. PubMed ID: 4085642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism of viomycin inhibition of peptide elongation in bacteria.
    Holm M; Borg A; Ehrenberg M; Sanyal S
    Proc Natl Acad Sci U S A; 2016 Jan; 113(4):978-83. PubMed ID: 26755601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.